Communications Biology (Jan 2021)
The antimicrobial potential of cannabidiol
- Mark A. T. Blaskovich,
- Angela M. Kavanagh,
- Alysha G. Elliott,
- Bing Zhang,
- Soumya Ramu,
- Maite Amado,
- Gabrielle J. Lowe,
- Alexandra O. Hinton,
- Do Minh Thu Pham,
- Johannes Zuegg,
- Neil Beare,
- Diana Quach,
- Marc D. Sharp,
- Joe Pogliano,
- Ashleigh P. Rogers,
- Dena Lyras,
- Lendl Tan,
- Nicholas P. West,
- David W. Crawford,
- Marnie L. Peterson,
- Matthew Callahan,
- Michael Thurn
Affiliations
- Mark A. T. Blaskovich
- Centre for Superbug Solutions, Institute for Molecular Bioscience, The University of Queensland
- Angela M. Kavanagh
- Centre for Superbug Solutions, Institute for Molecular Bioscience, The University of Queensland
- Alysha G. Elliott
- Centre for Superbug Solutions, Institute for Molecular Bioscience, The University of Queensland
- Bing Zhang
- Centre for Superbug Solutions, Institute for Molecular Bioscience, The University of Queensland
- Soumya Ramu
- Centre for Superbug Solutions, Institute for Molecular Bioscience, The University of Queensland
- Maite Amado
- Centre for Superbug Solutions, Institute for Molecular Bioscience, The University of Queensland
- Gabrielle J. Lowe
- Centre for Superbug Solutions, Institute for Molecular Bioscience, The University of Queensland
- Alexandra O. Hinton
- Centre for Superbug Solutions, Institute for Molecular Bioscience, The University of Queensland
- Do Minh Thu Pham
- Centre for Superbug Solutions, Institute for Molecular Bioscience, The University of Queensland
- Johannes Zuegg
- Centre for Superbug Solutions, Institute for Molecular Bioscience, The University of Queensland
- Neil Beare
- BDG Synthesis
- Diana Quach
- Linnaeus Bioscience Inc.
- Marc D. Sharp
- Linnaeus Bioscience Inc.
- Joe Pogliano
- Linnaeus Bioscience Inc.
- Ashleigh P. Rogers
- Infection and Immunity Program, Monash Biomedicine Discovery Institute and Department of Microbiology, Monash University
- Dena Lyras
- Infection and Immunity Program, Monash Biomedicine Discovery Institute and Department of Microbiology, Monash University
- Lendl Tan
- School of Chemistry and Molecular Biosciences, The University of Queensland
- Nicholas P. West
- School of Chemistry and Molecular Biosciences, The University of Queensland
- David W. Crawford
- Perfectus Biomed, LLC (formerly Extherid Biosciences)
- Marnie L. Peterson
- Perfectus Biomed, LLC (formerly Extherid Biosciences)
- Matthew Callahan
- Botanix Pharmaceuticals Ltd.
- Michael Thurn
- Botanix Pharmaceuticals Ltd.
- DOI
- https://doi.org/10.1038/s42003-020-01530-y
- Journal volume & issue
-
Vol. 4,
no. 1
pp. 1 – 18
Abstract
Blaskovich et al. demonstrate the antimicrobial applications of cannabidiol and cannabidiol analogs against a range of pathogenic bacteria, including the capacity to kill MRSA and the Gram-negative bacteria Neisseria gonorrhoeae. This article highlights the potential for cannabidiol in the age of antimicrobial resistance.
